EPIGRAL Q2 FY27 Results & Earnings Analysis
Sentiment: Neutral (Confidence: medium)
Earnings Summary
Epigral reported Q2 FY27 revenue growth of 28% YoY to INR752 crores, driven by volume growth and improved realizations, with PAT growing 26% to INR64 crores. However, EBITDA margins remained under pressure at 18% due to high raw material and energy costs from West Asia volatility and increased coal prices. The derivatives and specialty business contributed 57% of revenue. Management highlighted ongoing capex for CPVC and ECH expansions, progress on epoxy resin and MPP projects, and initiatives to reduce energy costs through renewables. The outlook for H2 FY27 is positive, with expectations of higher caustic soda prices and continued volume growth.
Management Tone
- Prepared Remarks: Good — Prepared remarks highlighted 28% revenue growth, 26% PAT growth, and progress on capacity expansions. Management expressed confidence in long-term growth and maintained capex plans.
- Q&A Session: Neutral — Analysts questioned margin decline, cost pressures, and competitive dynamics. Management provided some quantification (ECU realization, utilization rates) but acknowledged margin impact from high coal prices and global volatility.
Revenue Growth Drivers
- Volume growth
- Improved realizations
- High raw material prices from West Asia volatility
Growth vs Margin Focus
Management emphasized revenue growth of 28% YoY while acknowledging margin pressure and taking steps to mitigate costs through renewable energy and value-added products. Long-term target of INR5,000 crores revenue by FY31 with EBITDA margin in the range of 22-23%.
About Epigral Limited
Epigral Limited (EPIGRAL) is listed on NSE. View the latest earnings analysis, AI-powered insights, and sentiment data on StockMirror.